At LGH intital labs were notable for a lipase of 2254 which trended upward to 8117, normal Cr and WBC of 22.
Initial BUN was 22 but subsequently trended upward to 30.
RUQ US revealed common bile duct dilitation and an abnormal appearance of her pancreas.
CT scan of her abdomen and pelvis was performed and was concerning for necrosis, therefore were was transferred to the ICU where aggressive fluid repletion was initiated (at the time of transfer she has recieved 7 L. HCT demonstrated hemoconcentration (54) which remained stable despite fluids.
Saturations improved to 96% with 50% FiO2 via a venti mask.
On arrival to the MICU on [**2141-6-14**], patient's VS 157/79 105 18 95% on CMV with RR 16, Vt 400, FiO2 60%.
On ECHO on [**6-26**] was wnl.
A LUQ u/s showed no gallstones and minimal sludge.
Family History: Skin cancer in a grandfather   Physical Exam: VS: 98.6 132/68 107 22 95% RA; 0/10  pain   GEN: No apparent distress, somnolent HEENT: no trauma, pupils round and reactive to light and accommodation, no LAD, oropharynx clear, no exudates CV: regular rate and rhythm, no murmurs/gallops/rubs PULM: Clear to auscultation bilaterally, no rales/crackles/rhonchi GI: soft, non-tender, non-distended; no guarding/rebound EXT: no clubbing/cyanosis/edema; 2+ distal pulses; peripheral IV present NEURO: Alert to person and situation; CN II-XII grossly intact, global muscle weakness DERM: no lesions appreciated  Pertinent Results: [**2141-6-14**] Na 146 K 4.6 Cl 116 C02 20 BUN 30 Cr 0.7 Alb 2.6 Alk Phos 91 Bilirubin 0.7 (direct 0.1) AST 171 ALT 286 Tpro  6.3 Lipase 8117 [**6-14**] 1434 WBC 20.7 HgB 17.2 HCT 53.7 PLT 168 ABG BiPAP (PEEP 5, PS 5)7.20/41/85 Venti mask 10L  7.17/47/82  Micro:  urine cx [**Hospital1 487**] [**2141-6-13**] > 100,000 colonies of beta hemolytic group B strep  [**Hospital3 **] Imaging CT Abdomen Pelvis with contrast Severe acute pancreatitis with suggestion of early pancreatic necrosis Mildly distended gallbladder containing sludge and stones no definite CBD stone identified  US Gallbladder: Markedly abnormal appearance of the pancreas and gallbladder with prominent common bile duct.
CT Abdomen/Pelvis  CXR  [**Hospital1 487**]: Bilateral lower lobe infiltrates R > L No effusions, No pneumothroax CXR ([**Hospital1 18**] my read) Bilateral pleural effusions, some vasular prominence no focal consolidations  EKG: sinus at 137 Bpm LAD, isolated Q in V1  Admission labs: [**2141-6-15**] 12:05AM BLOOD WBC-16.8* RBC-5.27 Hgb-15.1 Hct-48.1* MCV-91 MCH-28.6 MCHC-31.3 RDW-14.4 Plt Ct-214 [**2141-6-15**] 12:05AM BLOOD Neuts-75* Bands-10* Lymphs-3* Monos-8 Eos-0 Baso-0 Atyps-1* Metas-3* Myelos-0 [**2141-6-15**] 12:05AM BLOOD PT-14.4* PTT-64.8* INR(PT)-1.3* [**2141-6-15**] 12:05AM BLOOD Glucose-229* UreaN-35* Creat-0.7 Na-141 K-3.8 Cl-112* HCO3-17* AnGap-16 [**2141-6-15**] 12:05AM BLOOD ALT-176* AST-87* AlkPhos-68 TotBili-0.7 [**2141-6-15**] 04:55AM BLOOD ALT-154* AST-71* LD(LDH)-793* AlkPhos-65 TotBili-0.7 [**2141-6-15**] 12:05AM BLOOD Lipase-980* [**2141-6-15**] 12:05AM BLOOD Albumin-2.7* Calcium-6.7* Phos-2.6* Mg-1.5* [**2141-6-15**] 01:23AM BLOOD Type-ART Temp-37.4 Rates-/16 Tidal V-400 PEEP-5 FiO2-60 pO2-96 pCO2-41 pH-7.23* calTCO2-18* Base XS--9 -ASSIST/CON Intubat-INTUBATED [**2141-6-14**] 11:23PM   TYPE-ART TEMP-37.4 [**2141-6-14**] 11:23PM   LACTATE-1.5  [**2141-6-14**] CT abdomen/pelvis IMPRESSION: 1.
This could be focal fatty sparing but other lesions such as FNH could be missed on CT in equilibrium phase.
When the patient's condition improves, a repeat ultrasound should be obtained.
CT abdomen and pelvis [**2141-6-18**] IMPRESSION: 1.
Interval increase in peripancreatic fluid around on the tail of the pancreas and gastric greater curvature, but fluid collections do not appear organized.
Echo [**2141-6-26**] The left atrium and right atrium are normal in cavity size.
LENIs [**6-26**] The visualized vessels are patent and compressible with normal flow and augmentation.
CT chest from [**6-25**] Pulmonary nodules measuring up to 7 mm, for which a followup CT in three to six months is recommended if the patient is high risk for malignancy and 6 to 12 months if low risk for malignancy based on [**Last Name (un) 8773**] study guidance.
ERCP was deferred during acute disease state given that no obstructing stones were identified on CT and RUQ U/S.
After intubation, a bronchoscopy was performed that did not reveal any evidence of lobar infiltrate consistent with aspiration or pna.
A CTA was performed that revealed relative [**Name (NI) 20534**] of [**Name (NI) **] consistent with ischemic changes, but no thrombus was identified.
LENIs were performed and did not demonstrate any evidence of clot and echo did not show right heart strain.
Chest X-ray showed improvement in bilateral effusion despite persistent ataelectasis.
Renal U/S was performed and did not reveal any signs of hydronephrosis.
Initial hyperglycemia treated with SSI and lantus resulted in next day hypoglycemia.
Hyperglycemic again on [**2141-7-2**] with glucose in 400s.
Iron studies c/w anemia of CD with ferritin of 859.
-consider transfusion if hct <21  # Leukocytosis, thrombocytosis: Peaked on [**6-30**].
Suspect that this may have been related to aspiration as her WBC and platelets are now improving.
CODE: Full (confirmed on this admission)  Transitional: - cholecystectomy or ERCP with sphincterotomy in the future - aspiration: on a dysphagia diet of ground solids and nectar-thick liquids - nutrition: continue tube feeds pending re-eval by nutritionist - CT chest: Pulmonary nodules measuring up to 7 mm, for which a followup CT in three to six months is recommended if the patient is high risk for malignancy and 6 to 12 months if low risk for malignancy based on [**Last Name (un) 8773**] study guidance.
- please uptitrate metoprolol to home dose (100mg) - uptitrate lisinopril to 40mg as tolerated - once diet is stable (and off TF) restart pt's outpatient diabetes regimen (actos and metformin)   Medications on Admission: Actos 15 mg daily Amlodipine 2.5 mg daily Aspirin 81 mg daily Galantamine 8 mg daily with food Lasix 20 mg PO daily lisinopril 40 mg daily Loratadine 10 mg daily metformin 500 mg [**Hospital1 **] Metoprolol tartrate 100 mg daily omeprazole 40 mg daily Pravastain 40 mg daily Verapamil 240 mg daily  Medications on Transfer Acetaminophen 650 PR q 4 PRN Calcium gluconate 1,000 q 6 PRN Heparin subQ insulin aspart meropenam 1 gram q 8 day 1 =[**6-14**] levofloxacin 750 mg IV daily day 1 = [**2141-6-14**] metoprolol 25 mg [**Hospital1 **] morphine 4 mg q 4 hr PRN pain ondansetron 4 mf q 8 PRN nausea Pantoprazole 40 mg IV daily  Discharge Medications: 1. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
